Abstracts

204 – Role of Spacer Peptide 2 in HIV-1 Replication

Background Structural studies have shown that the HIV-1 matrix (MA) protein assembles into hexamers of trimers beneath the viral membrane and undergoes a conformational rearrangement during virion maturation. A recent structural study suggested that this transition is triggered by binding of spacer peptide 2 (SP2), released during protease (PR)-mediated Gag processing, to MA. Although SP2-triggered…

559 – InSTI Resistance in HIV Patients on ART in Rwanda (2022-2023): CADRE Preliminary Analysis

Background In this study, we investigated integrase strand transfer inhibitor drug resistance mutations (INSTI-DRMs) in HIV patients receiving antiretroviral (ARV) treatment in Rwanda.  Methods A longitudinal cross-sectional survey used remnant viral load samples from 208 adults in Rwanda, stored at sixteen regional labs. Resistance was assessed by detecting specific drug resistance mutations (DRMs) in the…

847 – RV534 Trial: T-Cell Responses and HIV Reservoir Change in HIVIS-DNA/MVA-CMDR+TLR4 Vaccinated Youth

Background Therapeutic vaccines offer a promising strategy to boost immune responses, reduce the HIV reservoir and potentially achieve ART-free remission. In this study, we characterized HIV-specific T-cell responses and assessed their correlation with the intact HIV reservoir in the RV534 trial. Methods 25 youths (M/F=13/12; median age=15 years) with perinatal HIV, on ART since 6…

849 – Dolutegravir Pharmacokinetics During Standard- and High-Dose Rifampicin Among Children With TB/HIV

Background Current WHO-recommended rifampicin (RIF) dosage results in inadequate concentrations in most children, but high-dose RIF (RIF-HD) may improve outcomes and shorten treatment duration. The impact of RIF-HD on dolutegravir (DTG) exposures among young children is unknown. Methods We designed a non-randomized, open-label, phase I/II pharmacokinetic (PK) and safety trial (NCT05069688) to evaluate steady-state DTG…

1048 – Antibiotic Consumption Patterns in HIV and PrEP Cohorts With Recurrent STI

Background Antimicrobial resistance (AMR) is a growing public health concern, driven by excessive antibiotic exposure. People living with HIV (PLHIV) and users of pre-exposure prophylaxis (PrEP) experience high rates of sexually transmitted infections (STIs), potentially leading to disproportionate antibiotic consumption. Comparative, population-based data versus the general population remains scarce.  Methods We conducted a retrospective, population-based…

854 – Safety & Pharmacokinetics of Long-Acting Cabotegravir and Rilpivirine in Young Children 10 – < 40 kg

Background Long-acting cabotegravir (CAB-LA) plus long-acting rilpivirine (RPV-LA) are approved for maintenance of viral suppression in adults and adolescents at least 12 years and 35kgs with HIV-1 infection. IMPAACT 2036 (CRAYON) is a Phase I/II study evaluating oral (PO) and intramuscular (IM) CAB-LA+RPV-LA in virologically suppressed children 2-<12 years, with HIV-1. Here, we present all…

1052 – Longitudinal Enrollment and Churn in the AIDS Drug Assistance Program in 3 States, 2014-2021

Background The AIDS Drug Assistance Program (ADAP) provides access to antiretroviral therapy (ART) for low-income people with HIV (PWH). Enrollment churn—defined as disenrolling or re-enrolling in ADAP coverage—may impact ART access continuity, cause program and client administrative burden, and worsen health outcomes (i.e., loss of viral suppression). Churn has not been examined over long periods…

372 – In Vitro and In Vivo Cytolytic Capacity of Engineered CAR-T Cells Targeting CD4

Background Chimeric Antigen Receptor (CAR) technology holds considerable promise for advancing HIV-1 cure strategies. However, the elimination of all latently infected cells by targeting gp120 at the cell surface requires complete latency reversal, which remains an unresolved challenge. To bypass this limitation, we have engineered CAR-T cells directed against CD4, the primary HIV receptor, to…

658 – Progression of Aortic Valve Calcification and Its Association With Lipoprotein(a) in Aging Thai PLWH

Background Aortic valve calcification (AVC), which shares a similar pathophysiology with atherosclerosis, has been linked to increased cardiovascular mortality. This study aimed to evaluate AVC progression in PLWH and its association with lipoprotein(a) [Lp(a)], a genetically determined risk factor for atherosclerosis, together with traditional cardiovascular risk factors in aging PLWH receiving long-term suppressive antiretroviral therapy (ART). Methods…